DDIT4 silencing attenuates sevoflurane-induced ferroptosis via the mTOR pathway in neuronal cells
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05511-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Shijian Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Jing'an District Centre Hospital of Shanghai, Fudan University, No. 259 Xikang Road, Shanghai, 200040, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Ferroptosis, Neurons, Transcription Factors. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Jing'an District Municipal Health Commission Foundation for Key Developing Disciplines.
Abstract (Originalsprache)
DNA damage-inducible transcript 4 (DDIT4) participates in neuronal cell ferroptosis and can be upregulated by sevoflurane (Sev). This study aimed to explore whether silent DDIT4 can improve Sev-induced neuronal cell ferroptosis and its potential mechanism. HT22 and SH‑SY5Y cells were transfected with siDDIT4 and exposed to Sev with or without the mammalian target of rapamycin (mTOR) inhibitor rapamycin. In both HT22 and SH-SY5Y cells, Sev exposure increased DDIT4, promoted ferroptosis, and inhibited the mTOR pathway (all P < 0.05). DDIT4 knockdown improved HT22 and SH-SY5Y cell viability (both P < 0.05), reduced reactive oxygen species (ROS) (both P < 0.05), malondialdehyde (MDA) (both P < 0.05), and Fe2+ accumulation (both P < 0.01), while increasing glutathione peroxidase 4 (GPX4) (both P < 0.05). DDIT4 knockdown also elevated solute carrier family 7-member 11 (SLC7A11) expression in HT22 cells (P < 0.05). Additionally, DDIT4 knockdown activated the mTOR pathway in HT22 and SH-SY5Y cells (both P < 0.05). Notably, the addition of rapamycin abolished the protective effect of DDIT4 knockdown on Sev-induced ferroptosis in HT22 and SH-SY5Y cells (all P < 0.05). DDIT4 knockdown alleviates Sev-induced ferroptosis in neuronal cells by activating the mTOR pathway. The findings of this study support the possibility of DDIT4 as a therapeutic target for Sev-related neurotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Jing'an District Centre Hospital of Shanghai, Fudan University, No. 259 Xikang Road, Shanghai, 200040, China.
- Department of Intensive Care Medicine, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, 200040, China.
- Department of Intensive Care Medicine, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, 200040, China. 15921316221@163.com.
- Department of Intensive Care Medicine, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, 200040, China. 18017312700@163.com.
Förderung
- Jing'an District Municipal Health Commission Foundation for Key Developing Disciplines
Zitieren
APA
Yu, S., Xi, M., Chen, J., Yang, H., & Xu, Z. (2026). DDIT4 silencing attenuates sevoflurane-induced ferroptosis via the mTOR pathway in neuronal cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05511-6
Vancouver
Yu S, Xi M, Chen J, Yang H, Xu Z. DDIT4 silencing attenuates sevoflurane-induced ferroptosis via the mTOR pathway in neuronal cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05511-6
BibTeX
@article{Yu2026,
author = {Yu, Shijian and Xi, Minxuan and Chen, Jiawei and Yang, Hao and Xu, Zhihong},
title = {DDIT4 silencing attenuates sevoflurane-induced ferroptosis via the mTOR pathway in neuronal cells},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05511-6}
}
EUVIMED